LivaNova plc Stock
Price
Target price
€48.00
€48.00
-2.040%
-1.0
-2.040%
€66.35
19.07.24 / Frankfurt
WKN: A14156 / Symbol: LIVN / Name: LivaNova / Stock / Healthcare Equipment & Supplies / Mid Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
LivaNova plc Stock
We can see a decrease in the price for LivaNova plc. Compared to yesterday it has lost -€1.000 (-2.040%).
With 10 Buy predictions and not the single Sell prediction the community is currently very high on LivaNova plc.
As a result the target price of 66 € shows a positive potential of 37.5% compared to the current price of 48.0 € for LivaNova plc.
Pros and Cons of LivaNova plc in the next few years
Pros
?
B****
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
Cons
?
C******** o* t** e**********
?
S********** s********
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of LivaNova plc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| LivaNova plc | -2.040% | 0.840% | -5.882% | 2.564% | 2.564% | -28.358% | -25.581% |
| Neogen Corp. | -1.860% | 2.649% | 0.000% | - | - | - | - |
| Bio-Rad Labs Inc. A | -2.200% | -1.254% | 2.340% | -25.981% | -6.165% | -51.239% | - |
| Merit Medical Systems | -1.280% | -3.145% | 2.667% | 4.762% | 13.235% | 49.515% | 56.663% |
Comments
LivaNova PLC (NASDAQ: LIVN) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $72.00 price target on the stock.
Show more
Ratings data for LIVN provided by MarketBeat
LivaNova PLC (NASDAQ: LIVN) had its price target raised by analysts at Mizuho from $75.00 to $80.00. They now have a "buy" rating on the stock.
Show more
Ratings data for LIVN provided by MarketBeat
LivaNova PLC (NASDAQ: LIVN) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $72.00 price target on the stock.
Show more
Ratings data for LIVN provided by MarketBeat
News
LivaNova to Announce Second-Quarter 2024 Results
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, will host a conference call to discuss its second-quarter 2024 results on Wednesday, July 31, 2024 at 1 p.m. London time (8
LivaNova Provides Update on RECOVER Clinical Study Evaluating VNS Therapy for Treatment-Resistant Depression in Unipolar Patients
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced the preliminary results for the unipolar patient cohort of the RECOVER clinical study, assessing the use of
LivaNova to Present at the Goldman Sachs Healthcare Conference
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced Vladimir Makatsaria, Chief Executive Officer, will present in a fireside chat at the Goldman Sachs